Company intelligence / Profile preview

Novagen

Madison, Wisconsin, United States

Ownership: Private
Development stage: Other

Overview

Novagen was a pioneering provider of advanced molecular biology reagents, especially for gene splicing and protein purification, widely used in research but not in clinical drug development

Therapeutic areas: Other
Modalities: ProteinRecombinant proteinNucleic acid/protein reagentsMolecular biology tools
Industry: Chemicals & Materials

Partnerships

Distributed by Merck Biosciences/EMD Biosciences

Beyond the preview

Go deeper on Novagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novagen.

Explore the full profile